How have KTTAW shares performed this year?

Pasithea Therapeutics' stock was trading at $0.0180 at the start of the year. Since then, KTTAW stock has decreased by 9.4% and is now trading at $0.0163. View the best growth stocks for 2024 here .

How do I buy shares of Pasithea Therapeutics?

Shares of KTTAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:KTTAW

Pasithea Therapeutics (KTTAW) Stock Price, News & Analysis

$0.02

0.00 (0.00%)

(As of 07/26/2024 ET)

Compare

Today's Range: $0.0163
▼
$0.0163
50-Day Range: $0.0110
▼
$0.0199
52-Week Range: $0.00
▼
$0.12

Volume: 100 shs
Average Volume: 9,641 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Short Interest Trends

Get Pasithea Therapeutics alerts:

Ad Monument Traders Alliance

NEW AI developed by trader who won 1,129% (in 2 days)

Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...

Click here to see how >>>

About Pasithea Therapeutics

Pasithea Therapeutics Corp., a biotechnology company, engages in discovery, research, and development of treatments for central nervous system disorders, RASopathies, and other diseases. Its lead product candidate PAS-004, a next-generation macrocyclic mitogen-activated protein kinase, or MEK inhibitor for use in the treatment of a range of RASopathies, including neurofibromatosis type 1 oncology indications. The company intends to develop PAS-003, to treat amyotrophic lateral sclerosis; and PAS-001, to treat schizophrenia. Pasithea Therapeutics Corp. was incorporated in 2020 and is headquartered in Miami Beach, Florida.

KTTAW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KTTAW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive KTTAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:KTTAW
CUSIP: N/A
CIK: 1841330
Web: www.pasithea.com
Phone: 702-514-4174
Fax: N/A
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $486,559.00
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Dr. Lawrence Steinman BA (Age 76)
M.D., Ph.D., Co-Founder, MD & Executive Chairman
Comp: $250k
Dr. Tiago Reis Marques M.D. (Age 46)
Ph.D., CEO & Director
Comp: $480k
Mr. Daniel H. Schneiderman (Age 46)
Chief Financial Officer
Comp: $345.94k
Dr. Graeme Currie Ph.D. (Age 57)
Chief Development Officer
Comp: $346.62k
Dr. Yassine Bendiabdallah Ph.D. (Age 40)
COO & Head of UK Clinics

Key Competitors

View All Competitors

KTTAW Stock Analysis - Frequently Asked Questions

How have KTTAW shares performed this year?: Pasithea Therapeutics' stock was trading at $0.0180 at the start of the year. Since then, KTTAW stock has decreased by 9.4% and is now trading at $0.0163.
View the best growth stocks for 2024 here.
How do I buy shares of Pasithea Therapeutics?: Shares of KTTAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.